Cannabis
Nass Valley Gateway Ltd Announces It Will File Its 2020 EOY Audited Financials by Approximately May 18th, 2021, Well Within the Extension Granted by the BCSC
Vancouver, British Columbia–(Newsfile Corp. – May 5, 2021) – Nass Valley Gateway Ltd (CSE: NVG) (OTC Pink: NSVGF) (FSE: 3NVN) (the “Company”) and its management announce due to unforeseen delays in providing confirmation documents to its auditor (Manning Elliott LLP) resulting from COVID-19, it will be in default of the specific filing requirement. Management and its auditor are confident they will remedy the specific requirement by filing EOY 2020 Financials, MD&A report and all attending certifications by approximately May 18th, 2021, and well within the extension provided by the BCSC.
Management will satisfy the alternative information guidelines by publishing bi-weekly updates until the filing is completed.
Management will also comply with a management trading black-out until the filings have been completed within the extension. This black-out only restricts management and insiders, but not trading by the public.
There are no material changes or other items to report at this time.
ABOUT NASS VALLEY GATEWAY LTD.
Nass Valley Gateway Ltd. (CSE: NVG) (OTC Pink: NSVGF) (FSE: 3NVN)
Nass Valley Gateway LTD (NVG) is a publicly traded company on the CSE. In late 2018, Nass Valley Gateway agreed to merge with Advanced Bioceuticals Limited, a New Jersey LLC focused on the sales and distribution of made from organic hemp, non-GMO, CBD products. NVG CBD products will be sold under the “Nass Valley Gardens” brand via retail, wholesale, direct sales, and digital sales channels. NVG’s products target the general wellness, pain remediation, dermatology, sleep-aid, anti-aging, and beauty markets.
We seek Safe Harbor.
Neither the CSE nor its Regulation Services Provider has reviewed or accepts responsibility for the adequacy or accuracy of the contents of this news release.
Company: Nass Valley Gateway Ltd.
422 Richards Street, Suite 170
V6B 2Z4 Vancouver
Canada
Phone: 609-651-0032
E-mail: [email protected]
Internet: www.nassvalleygateway.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/83036
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
Cannabis
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Cannabis2 weeks ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 weeks ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
SCHWAZZE2 weeks ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 weeks ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis5 days ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis4 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan4 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey